ASTRIDE, NCT05468489: To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC |
|
|
| Recruiting | 3 | 200 | US | Serplulimab + chemotherapy (carboplatin-etoposide), Atezolizumab + chemotherapy (carboplatin-etoposide) | Shanghai Henlius Biotech | Extensive Stage Small Cell Lung Cancer | 10/24 | 12/25 | | |